当前位置：
X-MOL 学术
›
Aliment. Pharm. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Incidence, outcomes, and impact of COVID-19 on inflammatory bowel disease: propensity matched research network analysis
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2021-12-14 , DOI: 10.1111/apt.16730 Yousaf Hadi 1 , Parambir S Dulai 2 , Justin Kupec 1 , Nabeeha Mohy-Ud-Din 3 , Vipul Jairath 4 , Francis A Farraye 5 , Gursimran S Kochhar 3
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2021-12-14 , DOI: 10.1111/apt.16730 Yousaf Hadi 1 , Parambir S Dulai 2 , Justin Kupec 1 , Nabeeha Mohy-Ud-Din 3 , Vipul Jairath 4 , Francis A Farraye 5 , Gursimran S Kochhar 3
Affiliation
|
Accurate estimates for the risk of COVID-19 in IBD, and an understanding of the impact of COVID-19 on IBD course and the risk of incident post-infectious IBD are needed.
中文翻译：
COVID-19 对炎症性肠病的发病率、结果和影响：倾向匹配研究网络分析
需要准确估计 IBD 中 COVID-19 的风险，并了解 COVID-19 对 IBD 病程的影响以及感染后 IBD 事件的风险。
更新日期：2021-12-31
中文翻译：
COVID-19 对炎症性肠病的发病率、结果和影响：倾向匹配研究网络分析
需要准确估计 IBD 中 COVID-19 的风险，并了解 COVID-19 对 IBD 病程的影响以及感染后 IBD 事件的风险。
京公网安备 11010802027423号